Paget Paget
Paget Paget
  Educational Slide Program  

Approved Therapies for Paget's Disease of Bone in U.S.  
<< Back  
  Six prescription drugs are currently approved and available for treating Paget's disease in the U.S. There is one brand of parenteral salmon calcitonin. A nasal spray form of salmon calcitonin is approved for osteoporosis but not Paget's disease. Human calcitonin is no longer available. Five bisphosphonates are now approved. Four are oral (etidronate, alendronate, tiludronate, and risedronate) and one is intravenous (pamidronate).

Because the frequency of associated secondary osteoarthritis, nonsteroidal anti-inflammatory agents are often added to the specific therapies to help control pain.
    Previous Image | Next Image